Turning Cancer Patients and Caregivers Into Informed Decision- Makers 

 

Hi, my name is David Emerson, and I have been living with an incurable cancer called Multiple Myeloma since 1994. I started PeopleBeatingCancer.org because I believe that there is a problem with cancer care today.  Cancer patients and caregivers are asked to make huge decisions about their health-- often while woefully uninformed, and under an extreme time crunch. How many of you are here because you were given 24 hours to approve your chemotherapy regimen? 

​Let me be clear: knowledge is power. The more you know, the better decisions you'll make for your care.  Yes, I said YOU. You are in control. This website and the non-profit organization that supports it are dedicated to helping cancer survivors and caregivers become informed, educated decision-makers about their treatment. All information found on this site is evidence-based with the studies cited, and actionable-- you can get started using the protocols right away.

Welcome!

​

Check out our latest blog posts:

Myeloma Cancer Coaching-Antineoplaston Therapy for Refractory Myeloma
"Yes, I am still in CR from my refractory MM and have been since I completed ANP therapy in 4/99.[...]
Read More 
Lasix Side Effects-Is Furosemide Necessary for Stable Heart Failure?
Lasix reduces fluid yet also causes a host of side effects. The study linked below questions the need for Lasix[...]
Read More 
Pancreatic Cancer-Pharmacologic Ascorbic Acid, Curcumin, Bitter Melon?
The patient survived nearly 4 years after diagnosis (pancreatic cancer), with PAA as his sole treatment, and he achieved objective[...]
Read More 
Myeloma Survivor- Got Chemobrain? Get Aromatherapy, Essential Oils
"Clinical trials have examined (essential oils) use in patients with cancer (multiple myeloma) for anxiety, nausea, vomiting and other health-related[...]
Read More 
Is a Diagnosis of “Plasma Cell Dyscrasia” a Diagnosis of MGUS, SMM or MM?
"Plasma cell dyscrasias (MGUS, SMM, MM) are a heterogeneous group of disorders caused by the monoclonal proliferation of lymphoplasmacytic cells in[...]
Read More 
Multiple Myeloma-Non-Toxic Venous Thromboembolism (VTE) Risk Reduction
“With an aging population and a rising prevalence of obesity and cancer (MM), the incidence of VTE is expected to[...]
Read More